Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $32.67

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven analysts that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is $32.67.

A number of research analysts recently issued reports on the company. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research note on Friday. Barrington Research restated an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Stifel Nicolaus dropped their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a research note on Thursday, July 18th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research note on Monday, July 22nd. Finally, Evercore ISI dropped their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY traded down $1.10 during midday trading on Friday, hitting $23.31. 3,688,608 shares of the company's stock traded hands, compared to its average volume of 2,965,741. DENTSPLY SIRONA has a 1 year low of $22.85 and a 1 year high of $37.60. The stock has a market capitalization of $4.84 billion, a price-to-earnings ratio of -52.98, a price-to-earnings-growth ratio of 1.17 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The firm has a fifty day moving average of $25.22 and a 200 day moving average of $26.43.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company's revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.51 earnings per share. On average, analysts forecast that DENTSPLY SIRONA will post 1.98 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.75%. The ex-dividend date was Friday, September 27th. DENTSPLY SIRONA's payout ratio is -145.45%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after buying an additional 753 shares in the last quarter. LRI Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Rothschild Investment LLC acquired a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $32,000. Allworth Financial LP boosted its stake in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 625 shares during the last quarter. Finally, Central Pacific Bank Trust Division acquired a new stake in shares of DENTSPLY SIRONA in the first quarter worth approximately $64,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.